Sprint Bioscience (Sweden) Market Value
| SPRINT Stock | SEK 1.36 0.06 4.62% |
| Symbol | Sprint |
Sprint Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sprint Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sprint Bioscience.
| 05/01/2023 |
| 04/25/2024 |
If you would invest 0.00 in Sprint Bioscience on May 1, 2023 and sell it all today you would earn a total of 0.00 from holding Sprint Bioscience AB or generate 0.0% return on investment in Sprint Bioscience over 360 days. Sprint Bioscience is related to or competes with Stille AB, Precio Fishbone, C Rad, and Novotek AB. Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism More
Sprint Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sprint Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sprint Bioscience AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.31 | |||
| Information Ratio | 0.0833 | |||
| Maximum Drawdown | 31.26 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 11.32 |
Sprint Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sprint Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sprint Bioscience's standard deviation. In reality, there are many statistical measures that can use Sprint Bioscience historical prices to predict the future Sprint Bioscience's volatility.| Risk Adjusted Performance | 0.0706 | |||
| Jensen Alpha | 0.6355 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0965 | |||
| Treynor Ratio | (1.33) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sprint Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sprint Bioscience Backtested Returns
Sprint Bioscience appears to be abnormally volatile, given 3 months investment horizon. Sprint Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0962, which indicates the firm had a 0.0962% return per unit of risk over the last 3 months. By inspecting Sprint Bioscience's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please review Sprint Bioscience's Risk Adjusted Performance of 0.0706, coefficient of variation of 1012.01, and Semi Deviation of 4.4 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sprint Bioscience holds a performance score of 7. The entity has a beta of -0.45, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sprint Bioscience are expected to decrease at a much lower rate. During the bear market, Sprint Bioscience is likely to outperform the market. Please check Sprint Bioscience's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Sprint Bioscience's existing price patterns will revert.
Auto-correlation | -0.45 |
Modest reverse predictability
Sprint Bioscience AB has modest reverse predictability. Overlapping area represents the amount of predictability between Sprint Bioscience time series from 1st of May 2023 to 28th of October 2023 and 28th of October 2023 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sprint Bioscience price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Sprint Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Sprint Bioscience lagged returns against current returns
Autocorrelation, which is Sprint Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sprint Bioscience's stock expected returns. We can calculate the autocorrelation of Sprint Bioscience returns to help us make a trade decision. For example, suppose you find that Sprint Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sprint Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sprint Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sprint Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sprint Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Sprint Bioscience Lagged Returns
When evaluating Sprint Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sprint Bioscience stock have on its future price. Sprint Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sprint Bioscience autocorrelation shows the relationship between Sprint Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Sprint Bioscience AB.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Check out Sprint Bioscience Correlation, Sprint Bioscience Volatility and Sprint Bioscience Alpha and Beta module to complement your research on Sprint Bioscience. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Sprint Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.